Magle Group, a leading healthcare innovator listed on Nasdaq First North Growth Market, has signed a binding term sheet to acquire all shares in PK Biotech ApS...

Leadership advisor Tune Hein shares exclusive insights from his five-year experience as an internal specialist at Novo Nordisk during the launch of Wegovy, one of the pharmaceutical industry's most significant obesity drug introductions. What are the 10 core beliefs that propelled Novo Nordisk to become one of the world's most valuable companies, and how did their unconventional approach to scaling, management, and organizational structure drive their success in the competitive obesity drug market?

While we have, in some ways, moved beyond the pandemic, mental health continues to grow in importance as a workplace issue, and indeed as an issue in society at large.

Following public debate and the media's intense focus on questionable independency cases, the Danish government now strikes a blow for the cooperation between health care professionals and the industry, claiming the cooperation to be necessary and important as health care professionals possess useful knowledge for the industry.

ENLI has prepared a new separate guide that summarises relevant information about pharmaceutical companies' access to provide information material and medical devices to healthcare professionals.

Following the approval of the European Parliament in December, the Council of the European Union has on the 21 January 2025 adopted the European Health Data Space Regulation, paving way for implementation of the Regulation.

From 1 March 2012 the Danish Medicines Agency will no longer exist as an independent agency.

The Ministry of the Interior and Health of Denmark as well as the Danish Regions and the Danish Association of the Pharmaceutical Industry (LIF) have all agreed to extend the existing price cap agreements...

Just before Christmas, following debate in the Danish media on the Industry's use of HCPs as consultants, the Danish Industry Board, ENLI, clarified the rules on the Industry's use of HCPs as consultants.

A government-appointed working group has identified a number of areas where the pharmacies' competencies can be further utilized.

Danish Regions has decided that the Danish Treatment Council and the Danish Regions' Clinical Quality Development Programme...

The Danish Board for Health Apps has recently published its first five recommendations of health apps.

The Danish company TÜV SÜD Danmark ApS has been designated as a new notified body for the certification of medical devices.

On June 20 2022, the European Commission ("Commission") published the opening of an investigation into a possible anticompetitive disparagement campaign by a Swiss based manufacturer of products...

The European Commission has just adopted Implementing Regulation (EU) 2024/1381 laying down procedural rules for common clinical assessments of cancer and ATMP...

The newly adopted proposal to amend the Medicines Act aims to ensure that selected pharmaceutical companies have safety stockpiles that can meet the need for critical medicines...

In connection with the publication of ENLI's newsletter on 20 March 2023, a number of interesting decisions have been published. These concern, among other things: The boundary between information...

On 1 January 2024, an amending act on the ethical conduct of health research and health data research projects came into force.

New proposals for amendments to the Medicines Act, the health Act and the Committee Act have been presented.

Polycystic Ovary Syndrome has been officially renamed Polyendocrine Metabolic Ovarian Syndrome following a 14-year global medical consensus. The new terminology better reflects the condition's complex hormonal, metabolic and reproductive nature, moving beyond the misleading reference to ovarian cysts. What does this fundamental shift in medical understanding mean for patent applications and intellectual property strategy in women's health innovation?